TITLE

UROLOGIX REPORTS 4TH QTR 2007 NET LOSS OF $12.1 MIL

PUB. DATE
October 2007
SOURCE
Biotech Financial Reports;Oct2007, Vol. 14 Issue 10, p1
SOURCE TYPE
Trade Publication
DOC. TYPE
Article
ABSTRACT
The article focuses on the financial performance of Urologix Inc., a manufacturer of minimally invasive medical products in Minneapolis, Minnesota, for the fourth quarter of 2007. The company has reported a $4.8 million revenue compared to $5.1 million in the third quarter of 2007 and $6.6 million in the fourth quarter of fiscal 2006. Meanwhile, it cites that the net loss of the company for the fourth quarter is $12.1 million or $0.84 per diluted share.
ACCESSION #
26765827

 

Related Articles

  • Urologix to Host Its Fiscal 2011 3rd qtr Conference Call.  // Biomedical Market Newsletter;5/7/2011, p204 

    The article offers information on the conference call to be hosted by Urologix Inc. on its fiscal 2011 3rd quarter results to be held on April 26, 2011.

  • Urologix to Host Its FY 2012 Second Quarter Conference Call.  // Biomedical Market Newsletter;1/21/2012, Vol. 21, p1 

    The article offers information on a conference call to be hosted by Urologix Inc. on January 24, 2012 in which it will release fiscal year 2012 second quarter results.

  • Urologix to Host Its Fiscal Year 2012 and Fourth Qtr Conference Call.  // Biomedical Market Newsletter;8/22/2012, Vol. 21, p1 

    The article offers information on a conference call to be hosted by Urologix Inc. to present fiscal year 2012 and 4th quarter results on August 23, 2012.

  • Urologix to Host Its FY 2012 3rd Qtr Conference Call.  // Biomedical Market Newsletter;4/21/2012, Vol. 21, p1 

    The article offers information on a conference call to be hosted by Urologix Inc. on April 26, 2012 in which it will release its financial results for third quarter of fiscal year 2012.

  • Earnings improve for publicly traded firms. Schliesman, Kyle // Inside Tucson Business;5/3/2004, Vol. 13 Issue 44, p1 

    Reports that annual earnings for publicly owned companies with operations in Tucson, Arizona took a positive turn in 2003. Levels of corporate profits; Use of the financial reports to determine industry trend; Major industries performing well in the city.

  • SPECTRANETICS REPORTS 3RD QTR '03 NET INCOME UP 57%.  // Biotech Financial Reports;Dec2003, p6 

    Colorado Springs, Colorado-based biotechnology firm Spectranetics Corp. has reported financial results for the third quarter and nine months ended September 30, 2003. Net income for the third quarter of 2003 was $357,000, or $0.01 per share on a fully diluted basis, up 57% from $227,000, or...

  • SYNOVIS LIFE REPORTS 39% REVENUE GROWTH FOR 3RD FISCAL QTR.  // Biotech Financial Reports;Oct2007, Vol. 14 Issue 10, p4 

    The article focuses on the financial performance of Synovis Life Technologies Inc., manufacturer of surgical supplies in Saint Paul, Minnesota, for the third quarter of 2007. The company has reported a net revenue of $18.2 million which is 39% above the $13.1 million in 2006, and a 10%...

  • Wheatland parent posts strong growth.  // Journal of Business (10756124);2/12/2004, Vol. 19 Issue 4, pA21 

    Reports financial statements of the Community Financial Group Inc. in Spokane, Washington. Corporate profit; Assets.

  • Contingent liability.  // Accountancy;Jul94, Vol. 114 Issue 1211, p94 

    Reports that bus and coach company Badgerline has restated its figures for 1993 following the results of a public inquiry into a planning application involving the Bath depot in England. Pre-tax profit; Loss before tax.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics